University of Alberta
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1908-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ualberta.ca
Dabigatran Following Transient Ischemic Attack and Minor Stroke
Phase 2
Completed
- Conditions
- Transient Ischemic AttackMinor Ischemic Stroke
- Interventions
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 300
- Registration Number
- NCT02295826
- Locations
- 🇨🇦
Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦University of Calgary, Calgary, Alberta, Canada
🇨🇦University of Alberta, Edmonton, Alberta, Canada
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
Phase 2
Terminated
- Conditions
- Intracerebral Hemorrhage
- Interventions
- Drug: labetalol/hydralazine/enalapril
- First Posted Date
- 2014-11-04
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 142
- Registration Number
- NCT02281838
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Rivaroxaban Acute Stroke Safety Study
Completed
- Conditions
- Transient Ischemic AttackAcute Ischemic Stroke
- First Posted Date
- 2014-10-31
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 50
- Registration Number
- NCT02279940
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Comparison of Active vs. Passive Surveillance to Collect Adverse Events
Not Applicable
Completed
- Conditions
- Adverse Events
- Interventions
- Other: Passive SurveillanceOther: Active Surveillance
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 96
- Registration Number
- NCT02268331
- Locations
- 🇨🇦
CARE, Edmonton, Alberta, Canada
Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection
Not Applicable
Completed
- Conditions
- Shoulder PainHead Neck Cancer
- Interventions
- Device: Grass SD9 Stimulator
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2020-05-07
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 68
- Registration Number
- NCT02268344
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Effects of Home Based Exercise Therapy in Early Cirrhosis
Not Applicable
Completed
- Conditions
- Cirrhosis
- Interventions
- Behavioral: Home based Aerobic exercise training
- First Posted Date
- 2014-10-17
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 40
- Registration Number
- NCT02267421
- Locations
- 🇨🇦
University of Alberta, Mazankowski Heart Institute, Edmonton, Alberta, Canada
FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff
Phase 2
Completed
- Conditions
- Enterocolitis Clostridium Difficile Recurrent
- Interventions
- Biological: Fecal Microbiota Transplant
- First Posted Date
- 2014-10-02
- Last Posted Date
- 2019-10-24
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 116
- Registration Number
- NCT02254811
- Locations
- 🇨🇦
Foothills Hospital, Calgary, Alberta, Canada
🇨🇦University of Alberta Hospital, Edmonton, Alberta, Canada
Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
Phase 1
Completed
- Conditions
- Hepatic Encephalopathy
- Interventions
- Biological: Fecal Microbiota Transplant
- First Posted Date
- 2014-10-02
- Last Posted Date
- 2021-10-04
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 4
- Registration Number
- NCT02255617
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
Effect of Lumbar Bracing on Spinal Function
Not Applicable
Completed
- Conditions
- Low Back Pain
- Interventions
- Device: Lumbar corset (Quickdraw, Aspen Medical Products)
- First Posted Date
- 2014-09-29
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 54
- Registration Number
- NCT02251106
A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
Phase 2
Completed
- Conditions
- Overactive BladderMild Cognitive Impairment
- Interventions
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 47
- Registration Number
- NCT02240459
- Locations
- 🇨🇦
Division of Geriatric Medicine, Clinical Sciences Building, University of Alberta Hosp, Edmonton, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath